In fiscal year 2019 , the Japanese pharmaceutical company Takeda Pharmaceutical Co. , Ltd. held assets worth approximately 12.82 trillion Japanese yen , significantly up from around 4.11 trillion Japanese yen in the fiscal year 2017 . The sharp increase resulted mainly from the acquisition of the biopharmaceutical company Shire . Takeda Pharmaceutical Co. , Ltd. focuses mainly on the therapeutic areas oncology , gastroenterology and neuroscience .
